252 related articles for article (PubMed ID: 18635970)
21. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
22. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth.
Kushner JA; Ciemerych MA; Sicinska E; Wartschow LM; Teta M; Long SY; Sicinski P; White MF
Mol Cell Biol; 2005 May; 25(9):3752-62. PubMed ID: 15831479
[TBL] [Abstract][Full Text] [Related]
23. The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
Li Y; Glozak MA; Smith SM; Rogers MB
Exp Cell Res; 1999 Dec; 253(2):372-84. PubMed ID: 10585260
[TBL] [Abstract][Full Text] [Related]
24. A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver.
Wu H; Reizel T; Wang YJ; Lapiro JL; Kren BT; Schug J; Rao S; Morgan A; Herman A; Shekels LL; Rassette MS; Lane AN; Cassel T; Fan TWM; Manivel JC; Gunewardena S; Apte U; Sicinski P; Kaestner KH; Albrecht JH
Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17177-17186. PubMed ID: 32631996
[TBL] [Abstract][Full Text] [Related]
25. Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.
Wang H; Kumar TR
Gene Expr Patterns; 2012; 12(3-4):136-44. PubMed ID: 22289519
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis.
Belsõ N; Széll M; Pivarcsi A; Kis K; Kormos B; Kenderessy AS; Dobozy A; Kemény L; Bata-Csörgõ Z
J Invest Dermatol; 2008 Mar; 128(3):634-42. PubMed ID: 17882269
[TBL] [Abstract][Full Text] [Related]
27. G1-phase regulators, cyclin D1, cyclin D2, and cyclin D3: up-regulation at gastrulation and dynamic expression during neurulation.
Wianny F; Real FX; Mummery CL; Van Rooijen M; Lahti J; Samarut J; Savatier P
Dev Dyn; 1998 May; 212(1):49-62. PubMed ID: 9603423
[TBL] [Abstract][Full Text] [Related]
28. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
Chen B; Pollard JW
Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
[TBL] [Abstract][Full Text] [Related]
30. Crucial roles of D-type cyclins in the early stage of adipocyte differentiation.
Hishida T; Naito K; Osada S; Nishizuka M; Imagawa M
Biochem Biophys Res Commun; 2008 May; 370(2):289-94. PubMed ID: 18374658
[TBL] [Abstract][Full Text] [Related]
31. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
Pignataro L; Sambataro G; Pagani D; Pruneri G
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1.
Teixeira A; Chaverot N; Strosberg AD; Cazaubon S
J Neurochem; 2000 Mar; 74(3):1034-40. PubMed ID: 10693934
[TBL] [Abstract][Full Text] [Related]
33. Physical interaction of the retinoblastoma protein with human D cyclins.
Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
[TBL] [Abstract][Full Text] [Related]
34. Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas.
Mermelshtein A; Gerson A; Walfisch S; Delgado B; Shechter-Maor G; Delgado J; Fich A; Gheber L
Br J Cancer; 2005 Aug; 93(3):338-45. PubMed ID: 16012517
[TBL] [Abstract][Full Text] [Related]
35. Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.
Ledda-Columbano GM; Pibiri M; Loi R; Perra A; Shinozuka H; Columbano A
Am J Pathol; 2000 Jan; 156(1):91-7. PubMed ID: 10623657
[TBL] [Abstract][Full Text] [Related]
36. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously Reported Gene Expression Profile Patterns in Plasma Cell Myeloma.
Mansoor A; Akhter A; Pournazari P; Mahe E; Shariff S; Farooq F; Elyamany G; Shahbani-Rad MT; Rashid-Kolvear F
Appl Immunohistochem Mol Morphol; 2015; 23(5):327-33. PubMed ID: 25265432
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1.
Kato JY; Sherr CJ
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11513-7. PubMed ID: 7505440
[TBL] [Abstract][Full Text] [Related]
38. Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth.
Ilyin GP; Glaise D; Gilot D; Baffet G; Guguen-Guillouzo C
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G115-27. PubMed ID: 12646420
[TBL] [Abstract][Full Text] [Related]
39. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
40. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.
Friedrichsen BN; Richter HE; Hansen JA; Rhodes CJ; Nielsen JH; Billestrup N; Møldrup A
Mol Endocrinol; 2003 May; 17(5):945-58. PubMed ID: 12586844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
